Table 1 Comparison of HPV type-specific prevalence among HPV-positive women from the general population and with ICC
From: Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria
HPV type | General Population (N = 245) | ICC (N = 68) | Â |
|---|---|---|---|
| Â | n (%, 95% CI) | n (%, 95% CI) | Prevalence ratio (95% CI) |
16 | 30 (12.2, 8.4 - 17.0) | 46 (67.6, 55.2 - 78.5) | 5.5 (3.7-8.3) |
18 | 18 (7.3, 4.4 - 11.4) | 7 (10.3, 4.2 - 20.1) | 1.4 (0.6-3.3) |
45 | 19 (7.8, 4.7 - 1.8) | 4 (5.9, 1.6 - 14.4) | 0.8 (0.3-2.2) |
35 | 30 (12.2, 8.4 - 17.0) | 4 (5.9, 1.6 - 14.4) | 0.5 (0.2-1.3) |
56 | 22 (9.0, 5.1 - 12.3) | 4 (5.9, 1.6 - 14.4) | 0.7 (0.2-1.9) |
51 | 14 (5.7, 3.2 - 9.4) | 3 (4.4, 0.9 - 12.4) | 0.8 (0.2-2.7) |
31 | 27 (11.0, 7.4 - 15.6) | 1 (1.5, 0.1 - 7.9) | 0.1 (0.0-0.7) |
33 | 5 (2.0, 0.7 - 4.7) | 1 (1.5, 0.1 - 7.9) | 0.7 (0.0-4.1) |
39 | 6 (2.4, 0.9 - 5.3) | 1 (1.5, 0.1 - 7.9) | 0.6 (0.0-3.4) |
73 | 4 (1.6, 0.4 - 4.1) | 1 (1.5, 0.1 - 7.9) | 0.9 (0.0-5.2) |
52 | 13 (5.3, 2.9 - 8.9) | 0 (0.0, 0.0 - 5.2) | 0.0 (0.0-0.99) |
58 | 21 (8.6, 5.4 -12.8) | 0 (0.0, 0.0 - 5.2) | 0.0 (0.0-0.6) |
68 | 2 (0.8, 0.1 - 2.8) | 0 (0.0, 0.0 - 5.2) | 0.0 (0.0-6.8) |
82 | 4 (1.6, 0.4 - 4.1)a | 0 (0.0, 0.0 - 5.2) | 0.0 (0.0-3.4) |
Any high-risk | 169 (69.0, 62.8 - 74.7) | 67 (98.5, 92.1 - 99.9) | 1.4 (1.1-1.9) |
Any low-risk | 110 (44.9, 38.6 - 51.4) | 2 (2.9, 0.4 - 10.2) b | 0.1 (0.0-0.2) |
Any multiple | 68 (27.8, 22.2 - 33.8) | 5 (7.4, 2.4 - 16.3) c | 0.3 (0.1-0.6) |
16/18 | 47 (19.2, 14.4 - 24.7) | 53 (77.9, 66.2 - 87.1) | 4.1 (2.8-5.8) |
16/18/31/33/45 | 90 (36.7, 30.7 - 43.1) | 58 (85.2, 74.6 - 92.7) | 2.3 (1.7-3.2) |